SCHEMBL3401769

SCHEMBL3401769

CC(CO)NC(=O)c1cccc(NS(=O)(=O)CC2CN(C(c3ccc(Cl)cc3)c3ccc(Cl)cc3)C2)c1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.41
FGFR1 P11362 3/20 0.41
KDR P35968 3/20 0.41
HPGD P15428 2/20 0.38
UTS2R Q9UKP6 6/20 0.37
MAP3K5 Q99683 1/20 0.37
ACKR3 P25106 1/20 0.37
NPC1 O15118 3/20 0.36
ALDH1A1 P00352 1/20 0.36
USP36 Q9P275 1/20 0.35
RAB9A P51151 2/20 0.35
KDM4E B2RXH2 1/20 0.35
CCR1 P32246 1/20 0.35
LMNA P02545 2/20 0.35
TP53 P04637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
F10 P00742 1/20 0.35
PRSS1 P07477 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3403104 0.92 EGFR (0.39) EGFRFGFR1KDRHPGDUTS2R
SCHEMBL3427255 0.92 EGFR (0.39) EGFRFGFR1KDRUTS2RMAP3K5
SCHEMBL977767 0.91 EGFR (0.39) EGFRFGFR1KDRHPGDUTS2R
SCHEMBL976523 0.90 EGFR (0.40) EGFRFGFR1KDRUTS2RMAP3K5
SCHEMBL976524 0.90 EGFR (0.40) EGFRFGFR1KDRUTS2RMAP3K5
SCHEMBL3406619 0.90 EGFR (0.38) EGFRFGFR1KDRUTS2RMAP3K5
SCHEMBL976516 0.90 EGFR (0.40) EGFRFGFR1KDRHPGDUTS2R
SCHEMBL977764 0.90 CCR2 (0.40) EGFRFGFR1KDRUTS2RMAP3K5
SCHEMBL976498 0.90 EGFR (0.38) EGFRFGFR1KDRUTS2RCCR1
SCHEMBL976385 0.90 EGFR (0.40) EGFRFGFR1KDRHPGDUTS2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2254862-A2 AZETIDINE-DERIVED COMPOUNDS, PREPARATION METHOD THEREFOR AND THERAPEUTIC USE OF SAME Sanofi-Aventis (FR) 2010-12-01 EP disclosed
WO-2009118473-A2 AZETIDINE-DERIVED COMPOUNDS, PREPARATION METHOD THEREFOR AND THERAPEUTIC USE OF SAME SANOFI-AVENTIS (FR) 2009-10-01 WO disclosed